Agents for treating mild cognitive impairment

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/08 (2006.01) A61K 31/137 (2006.01) A61K 31/18 (2006.01) A61K 31/575 (2006.01) A61K 38/05 (2006.01) A61K 38/06 (2006.01) A61K 45/00 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2471531

It is intended to provide remedies for mild recognition deflict which comprise compounds having an effect of inhibiting the production, secretion, aggregation and/or accumulation of .beta.-amyloid proteins, prodrugs thereof or salts of the same and inhibit the progress of mild recognition deflict into Alzheimer~s disease using the same.

L'invention concerne des remèdes permettant de soigner les troubles cognitifs légers. Ces remèdes renferment des composés qui inhibent la production, la sécrétion, l'agrégation et/ou l'accumulation de protéines beta-amyloïdes. L'invention concerne également des promédicaments ou des sels obtenus à partir de ces composés. Les remèdes de l'invention permettent également d'inhiber l'évolution des troubles cognitifs légers vers la maladie d'Alzheimer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Agents for treating mild cognitive impairment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agents for treating mild cognitive impairment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents for treating mild cognitive impairment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1581197

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.